Emma Hall
Researcher Next ID · RN-034616
Researcher · Medicine
London, Sweden
- Works count
- 503
- Citation count
- 26,557
- H-index
- 71
- i10-index
- 197
Research interests
Publications
Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials
The Lancet Oncology · 2021 · https://doi.org/10.1016/s1470-2045(20)30607-0
The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy
Frontiers in Oncology · 2020 · https://doi.org/10.3389/fonc.2020.01328
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
New England Journal of Medicine · 2015 · 10.1056/nejmoa1506859
Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study
The Lancet Oncology · 2011 · https://doi.org/10.1016/s1470-2045(11)70302-3
Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study
The Lancet Oncology · 2007 · https://doi.org/10.1016/s1470-2045(07)70003-7
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
The Lancet · 2007 · https://doi.org/10.1016/s0140-6736(07)60200-1
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
New England Journal of Medicine · 2004 · https://doi.org/10.1056/nejmoa040331
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: An overview of 6,633 patients from 27 randomized trials
Journal of Clinical Oncology · 1998
Current projects
No projects listed.